Clinical Trial Update: Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells [Phase 1]

View source ↗

Summary

Phase 1 trial of an autologous dendritic cell vaccine transfected with tumor antigen RNA and small inhibitory RNA for metastatic melanoma; the study assessing s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Autologous dendritic cell vaccine (tumor antigen RNA + small inhibitory RNA transfection)

Snippet

Sponsor: Scott Pruitt | Conditions: Metastatic Melanoma, Absence of CNS Metastases | Phase 1 | Status: COMPLETED